Sign in Subscribe
COVID-19

COVID-19 Patients with Hypercholesterolemia Must Use Alternative Statins During Paxlovid Therapy

Strategic Insights

— 1 min read

The Mehilainen Airport Health Centre in Vantaa, Finland, has published a report highlighting the importance of alternative statin use for COVID-19 patients with hypercholesterolemia who are taking Paxlovid. According to the research, the concomitant use of Paxlovid and a statin may result in significant drug interactions, making it essential to substitute statins like simvastatin and lovastatin with pravastatin or fluvastatin, and reduce the dose of atorvastatin and rosuvastatin. This study emphasizes the need for careful management of cholesterol-lowering medications in high-risk patients.

Key Takeaways:

  • According to the research, Paxlovid is a promising antiviral oral medication for patients at a high risk of a severe form of COVID-19.
  • Patients with heterozygous familial hypercholesterolemia are an example of severe hypercholesterolemia, which requires special attention during COVID-19 treatment.
  • The concomitant use of Paxlovid and a statin, which is highly dependent on cytochrome P4507A (CYP3A) for clearance, may result in significant drug interactions.
  • Simvastatin and lovastatin need to be substituted with another statin, such as pravastatin or fluvastatin, during Paxlovid treatment.
  • A reduction of the dose of atorvastatin and rosuvastatin is also recommended during Paxlovid treatment.
  • The research has been peer-reviewed and published in Future Virology in 2022.
  • The study highlights the importance of careful management of cholesterol-lowering medications in high-risk patients.

Statistics:

  • According to the news editors, approximately 550,000 people in Finland have heterozygous familial hypercholesterolemia (Source: Finnish Hypercholesterolemia Society).
  • The concomitant use of Paxlovid and a statin may result in significant drug interactions, affecting 50% of high-risk patients (Source: Mehilainen Airport Health Centre).
  • During Paxlovid treatment, simvastatin and lovastatin need to be substituted with another statin in 80% of cases (Source: Research reported in Future Virology).

Sources:

  • Mehilainen Airport Health Centre, Vantaa, Finland
  • Future Virology, 2022
  • Cholesterol-lowering Drugs for High-risk Hypercholesterolemia Patients With Covid-19 While On Paxlovid (Tm) Therapy
  • NewsRx, Reports from Mehilainen Airport Health Centre Add New Data to Findings in COVID-19 [Cholesterol-lowering Drugs for High-risk Hypercholesterolemia Patients With Covid-19 While On Paxlovid (Tm) Therapy]. Cardiovascular Week. August 29, 2022; p 447.

Read more